Emergent BioSolutions (EBS) Tops Q4 Views; Guides FY10 Sales Above the Street
Tweet Send to a Friend
Emergent BioSolutions (NYSE: EBS) reports Q4 EPS of $0.14, versus the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
